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Ischemic mitral regurgitation is an important consequence of LV remodeling after myocardial infarction.
Echocardiographic diagnosis and assessment of ischemic mitral regurgitation are critical to gauge its adverse
effects on prognosis and to attempt to tailor rational treatment strategy. There is no single approach to the
echocardiographic assessment of ischemic mitral regurgitation: standard echocardiographic measures of mitral
regurgitation severity and of LV dysfunction are complemented by assessments of displacement of the papillary
muscles and quantitative indices of mitral valve deformation. Development of novel approaches to understand
mitral valve geometry by echocardiography may improve understanding of the mechanism, clinical trajectory,
and reparability of ischemic mitral regurgitation.
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The mitral valve has a specific geometry designed to main-
tain leaflet coaptation and thereby prevent systolic regur-
gitation into the left atrium (LA). Mitral valve function
must be conceptualized in terms of a holistic relationship
with supporting ventricular structures, and thus derange-
ments of any part of the mitral valve apparatus – including
the mitral valve leaflets, but also the annulus, chordae
tendinae, papillary muscles (PM), and left ventricle (LV) –
can disrupt valvular coaptation and cause symptoms,
physical examination findings, and echocardiographic
manifestations of valvular incompetence. The concept
of ischemic mitral regurgitation must be clarified in
terms of possible mitral regurgitation (MR) mechanisms
as well as by acuity of the insult causing MR (see Table 1).
In acute coronary syndromes and early in the course of
myocardial infarction, MR may occur due to PM ischemia
or rupture due to infarction, ischemic LV dilation, and/or
increased LV diastolic pressures.
The most common clinical situation encountered for
MR arising post infarct, e.g. chronic ischemic mitral* Correspondence: jhung@partners.org
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article, unless otherwise stated.regurgitation (CIMR, also called “ischemic chronic sec-
ondary MR" by new guidelines [2]), is MR due to geomet-
ric changes of the LV and distortion of normal spatial
relationships of the mitral apparatus, all secondary to re-
modeling from ischemic heart disease. CIMR is character-
ized mechanistically by incomplete mitral leaflet closure,
namely displacement of the leaflet coaptation apically
within the LV cavity [3]. Although a spectrum of anatomic
abnormalities of both LV and PMs exists, evidence points
to a predominant role of “tethering” as the final common
pathway in inducing CIMR. Post-infarct, outward dis-
placement of PMs leads to stretching of the chordae
tendinae and increased tethering forces on the mitral
leaflets, which causes the apical coaptation and restricted
closure. Annular dilatation may also contribute by stretch-
ing leaflets and causing incomplete closure. Accordingly,
CIMR is classified as functional MR, or type IIIb in the
Carpentier classification. Practitioners should also be
mindful not to classify as CIMR those patients with mitral
regurgitation and comorbid ischemic heart disease if there
is any intrinsic mitral valve apparatus abnormality and/or
there has not been a history of myocardial infarction.
This article will focus specifically on the echocardio-
graphic characteristics of CIMR – given its importance
in adverse prognosis (e.g. heart failure and mortalityCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Classification of mitral regurgitation by
mechanism and acuity
Primary (“Organic”) Secondary (“Functional”)
Acute Papillary muscle ischemia Acute ischemic LV dilatation
Ruptured papillary muscle
(trauma, infarction)




Chronic Flail mitral valve leaflet Chronic ischemic mitral
regurgitation (CIMR)
Mitral valve prolapse Non-ischemic LV dilatation
(failure of leaflets to coapt)





Rheumatic Right ventricular pacing
Congenital Aortic insufficiency [1]
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ing revascularization, annuloplasty, and cardiac resynchro-
nization therapy. Echocardiography is the only reliable
method available for clinical evaluation of CIMR because
the physical examination reveals no audible murmurs in
about one-third of CIMR patients with moderate or severe
MR and half with mild MR [4].
Overview of echocardiographic assessment of CIMR
When assessing MR by echocardiography, the key inquiries
are severity, delineation of pathology in the components of
the mitral valve apparatus, overall mechanism of MR, and,
based on the probable mechanism, consideration of treat-
ment strategies to reduce MR. As applied to CIMR, the
echocardiographer should:
1) confirm underlying chronic ischemic heart disease,
2) gauge the severity of MR,
3) exclude intrinsic pathology in the leaflets and chordae,
4) establish CIMR as the most likely etiology by assessing
LV and PM displacement, and
5) characterize the phenotype of CIMR as either
symmetric or asymmetric.
Echocardiographic assessment of CIMR should also in-
clude assessment of global and regional LV function, LV
ejection fraction, LV dimensions, LV wall motion abnor-
malities, and pulmonary hypertension [2].
The prevalence of post-infarct MR has been reported
to be as high as 50% in patient populations studied by
echocardiography within 7 to 30 days post infarct [4,5].Thus echocardiography may be used to confirm sequelae
of ischemic heart disease such myocardial scarring, wall
thinning, and wall motion abnormalities. However, it is
incumbent on the cardiologist and echocardiographer to
be familiar with the patient’s history and other available
diagnostic results including electrocardiography, nuclear
perfusion tests, and angiography.
Concomitant with measuring severity of MR, one of
the initial jobs of the echocardiographer is to ensure
there is no other intrinsic pathology of the leaflets, chor-
dae, and PMs; identifying such a finding could indicate
the mechanism may not be CIMR. In general the patho-
logic processes underlying CIMR reflect ventricular and
not leaflet pathology: adverse local and global remodel-
ling of the LV changes the geometry of the PMs and the
resultant dynamic vector forces exerted on the chordae-
leaflet system. During systole, mitral leaflet closing is
mediated by the interplay of closing forces [6] exerted by
LV intracavitary systolic pressure on the ventricular sur-
face of the mitral leaflets versus tethering forces, which
restrict leaflet motion in systole by pulling apically away
from the mitral annular coaptation plane. Tethering
forces are applied by the LV, PMs, and annulus along ap-
ical, posterior, and lateral vectors [7] (Figure 1) and
cause incomplete systolic mitral leaflet closure [3].
Global LV dilatation will increase the distance from PM
to the leaflet and cause tethering; similarly, a local area
of infarction that distorts and outwardly displaces the
myocardium underlying PM produces similar malposi-
tion. In part because of the more common single vessel
supply of the posteromedial PM [8], tethering and re-
sultant CIMR are more common with inferior infarcts
than with anterior infarct [9]. In addition, displacement
of the anterolateral PM is more restricted due to the
structural buttress afforded by the interventricular
septum, and also because infarcts in the left coronary ar-
tery territory will more commonly produce apical dilata-
tion as opposed to dilatation of territory subtended by
the anterolateral PM.
The vector sum of forces applied to the mitral leaflet
in CIMR generates an abnormal, ventricularly displaced
coaptation shape of the mitral leaflets referred to as
“tenting”. Two echocardiographic phenotypes of tenting
in CIMR have been identified [7]: asymmetric and sym-
metric (Figure 2), which depends on if the posterior or
both leaflets are affected, which itself depends on the
underlying LV and PM derangements. For example, glo-
bal LV dilatation with radially outward and apical dis-
placement of both PMs causes symmetric tenting of
both leaflets. Inferoposterior infarction [10] with local
adverse remodelling predominantly affects the pos-
teromedial PM and restricts the posterior leaflet motion,
causing a relative overriding of the coaptation zone
by the non-tethered leaflet (“pseudoprolapse”). The
A B
Figure 1 Model of closing and tethering forces acting on the mitral valve. The forces acting on mitral valve leaflets are shown in model
parasternal short axis (A) and long axis (B) sections (green dashed line in (A) indicates the plane shown as (B)). The LV, LA, and aorta are shown
in gray and blue, with PMs indicated by hatched lines (since the PMs are not at the same level as the mitral annulus). The mitral annulus and
leaflets are shown in red with the aortomitral curtain in purple. Normal systolic closing forces include: LV contraction (green arrows), basal
myocardial clockwise rotation (blue arrow), and mitral annulus contraction (purple arrows). Tethering forces include passive constraint of the
mitral annulus (red arrows) and tethering from the PM-chordae and PM contraction (orange arrows). The relative size of the arrow delineates
relative magnitude of the forces acting on the mitral leaflets.
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metric tethering, is less geometrically deformed than in
asymmetric tethering. Regurgitant severity of CIMR is
strongly affected by tethering phenotype, with higher de-
grees and more eccentric jets observed in asymmetricFigure 2 Models of symmetric and asymmetric phenotypes of CIMR.
and B) and symmetric (panels C and D), based on the model established in
magnitude. An inferoposterior myocardial infarction (black area in panels A
direction, which displaces the posteromedial PM and increases tethering fo
(green arrows) and decreased basal clockwise rotation force (blue arrow). D
is posteriorly directed eccentric MR (green shaded area). Global LV dilatatio
D) displaces both PMs with posterior, lateral, and apical vectors exerted on
reduced (green arrow). The enlarged mitral annulus contributes to higher p
annular contraction (red arrows). The net result is apical displacement of thtethering (Figure 3). Symmetric tethering, despite more
common association with worse LV dysfunction and dila-
tation, more frequently results in smaller non-eccentric
central jets of MR. The characteristics of these phenotypes
are summarized in Table 2.Figure 2 depicts two types of CIMR phenotypes, asymmetric (panels A
Figure 1, with arrows indicating the forces which have changed in
and B) causes local outpouching of the LV myocardium in a posterior
rces exerted on the leaflets. In addition, there is less LV closing force
ue to posterior > anterior leaflet tethering and pseudoprolapse, there
n and spherical remodelling (indicated by black areas of panels C and
the mitral leaflets (orange arrows). Aggregate LV closing force is
assive tethering force on the leaflets (red arrows) and less mitral




Figure 3 Echocardiographic images of asymmetric CIMR due to inferoposterior myocardial infarct and posterior leaflet tethering. These
echocardiographic images were obtained from an 81 year-old male with a history of inferior and inferoposterior myocardial infarction with
localized aneurysmal ventricular deformity and atrial fibrillation, when he was evaluated for dyspnea and congestive heart failure. The previous
echocardiogram obtained three years prior had demonstrated mild posteriorly directed MR. The apical two chamber view at end-diastole from
the current transthoracic echocardiogram shows the true inferobasal aneurysm indicated by an asterisk (A). Asymmetric mitral valve leaflet
tenting is depicted in the parasternal long-axis view at mid-systole (B). Additional quantitative measures of tethering phenotype are described in
the subsequent main text. The tenting height measured from the mitral annulus plane was 1.4 cm and the tenting area bounded by the mitral
annular plane and leaflets was 4.0 cm2; tethering angles β and α measured approximately 55° and 40° respectively. The jet of MR was posteriorly
directed and reported moderate in severity (C). TEE was then undertaken to confirm the mechanism of MR and this also revealed incomplete
mitral valve closure due to PM displacement (D: mid-esophageal long-axis view at omniplane angle 140°, image taken at mid-systole) with
pseudoprolapse (arrow) of the anterior leaflet tip relative to the more adversely tethered posterior leaflet. This locus of malcoaptation is the area
from which the MR originates. There is severe MR with an eccentrically directed posterior jet (E: mid-esophageal long-axis view at omniplane
angle 140°, image taken at mid-systole) with evidence of systolic flow reversal in pulmonary veins (not shown).
Dudzinski and Hung Cardiovascular Ultrasound 2014, 12:46 Page 4 of 16
http://www.cardiovascularultrasound.com/content/12/1/46In the following sections, transthoracic echocardio-
graphic techniques will be discussed in tandem with ref-
erence to the underlying plausible mechanisms of
CIMR and other etiologic contributors such as mitral
annular dilatation.
Echocardiographic assessment of ischemic MR severity
Accurate grading of MR is central to clinical decision-
making. MR should be graded using an integrative
approach, incorporating multiple Doppler techniques
for direct quantification as well as supportive data
(left atrial size, LV chamber size, pattern of pulmonary
vein flow) in the overall assessment [11]. Color Doppler
techniques include:A. Distal jet area measures the high turbulent mosaic
color Doppler pattern produced by the MR flow as
it enters the left atrium, distal to the mitral valve
leaflets. This color Doppler display is a surrogate
measure of MR volume. It is measured as an
absolute area, or also as a ratio relative to the left
atrial area. The MR jet area is traced at its
maximum in apical views and divided by the left
atrial area traced in same frame (Figure 4). The
advantage of jet area ratio is that it is a rapid,
straightforward method, especially for centrally
directed MR jets. Its disadvantages are that the distal
MR jet varies with loading conditions, such as blood
pressure, or technical factors such as machine color
Table 2 Characteristics of symmetric versus asymmetric CIMR tethering phenotypes
Symmetric CIMR Asymmetric CIMR
Major net tethering vectors Apical Posterior > apical
Tethered mitral leaflets Anterior and posterior Posterior
Associated myocardial infarct pattern
(and vessels)
Anterior (left anterior descending/multiple
coronary arteries)
Inferoposterior (right coronary > circumflex)
Archetype pattern of LV dysfunction Global LV dilatation and wall motion abnormality Inferoposterior wall motion abnormality and dilatation
Mitral valve coaptation zone
displacement
Apically Posteriorly; pseudoprolapse of anterior leaflet
over posterior leaflet
Tethering angles Anterior ≈ posterior Posterior > anterior
Tenting volume Higher Lower
MR origin and direction Central, non-eccentric Posterior, posteriorly eccentric
Annular dilatation Greater Lesser
Annular height Greater loss of non-planarity (“flattened”) Less loss of height
MR relative severity Less severe More severe
Severity correlates best with LV dilatation and sphericity Degree of mitral valve deformation (greater tethering
angles, more marked derangement of coaptation zone)
Figure 4 MR quantification by ratio of maximal distal jet area
to left atrial area. Assessment of MR severity by distal jet area
involves tracing the jet area (dashed white line) in the apical four
chamber view and comparing the ratio of jet area to the left atrial
area (solid white line). See Tables 3 and 4 for MR severity grades
corresponding to different jet area:left atrial area ratios.
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volume in eccentric jets is underestimated by the
distal jet area method as the jet can be attenuated by
the left atrial wall.
B. Vena contracta (VC) measures the linear dimension
of the neck of the MR jet as it enters the regurgitant
orifice at the level of the leaflets. The VC is a simple
linear measure of the regurgitant orifice and is
relatively independent of loading conditions. The VC
is measured in the parasternal long axis plane with
the VC region magnified, and depth and sector size
optimized for color Doppler resolution (Figure 5).
Magnification is critical for accurate vena contracta
grading, as small differences in measurement may
change in grading category. Because reference
ranges for VC have been defined in long axis planes,
measurement of VC in the 2 chamber view should
be avoided.
C. Proximal isovelocity surface area (PISA) or proximal
flow convergence method calculates the effective
regurgitant orifice area (EROA) and MR regurgitant
volume (RVol) as follows:
EROA ¼ 2πR2  Aliasing Velocity
 Peak Velocity of MR
where R is the radius of the hemispheric PISA zone
(Figure 6)MR RVol ¼ EROA  TVI of MR continuous wave
Doppler profileThe PISA method provides a quantitative method
for MR grading. However, the calculation requires a
Figure 5 Vena contracta measurement. The VC (white arrows) of
the MR jet is measured from parasternal long axis view as the
narrowest width of the proximal jet at the level of or just distal to
the leaflet tips. In this view, the image is zoomed into the area of
the VC (arrows), with sector size and depth selected to optimize
color Doppler resolution. Magnification is essential to correct
grading of MR severity by the VC method because small changes in
the measurement may affect severity grade. VC = vena contracta.
Figure 6 Calculation of EROA by PISA method. In this apical four
chamber view, the PISA region is displayed from a magnified apical
view, and the hemispheric PISA radius R is shown between the
crosshairs. Note the change of the color Doppler scale, with a
baseline shift in the direction of the MR jet (e.g. “down” in this
example). The aliasing velocity is 30.8 cm/s. EROA can be calculated
as the product of 2πR2 x Aliasing Velocity ÷ Peak Velocity of MR
(peak velocity not shown). The vena contracta is indicated as the
distance between the two arrows. EROA = effective regurgitant
orifice area; PISA = proximal isovelocity surface area.
Table 3 Guideline based reference ranges for grading mr
2003 ASE guidelines
2003 ase guidelines
Parameter Mild Moderate Severe
EROA-CIMR (cm2) ≥ 0.2
EROA-Primary MR (cm2) < 0.2 0.2-0.39 ≥ 0.4
VC width (cm) < 0.3 0.3-0.69 ≥ 0.7
Jet/LA area < 20% 20-39% ≥ 40%
MR Reg. Volume < 30 ml 30-59 ml ≥ 60 ml
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the PISA region which is not always the case.
Additionally, it can be technically challenging to
measure the PISA radius accurately.
D. The pulsed Doppler volumetric method calculates
MR RVol as mitral valve inflow minus aortic
outflow. Although it provides a quantitative measure
of MR, it has multiple measurement steps, each with
potential for measurement variability and error.
Additionally, this method requires two non-stenotic
valves without important aortic insufficiency.
Tables 3 and 4 shows reference ranges for color Doppler
criteria for MR grade based on 2003 American Society
of Echocardiography guidelines [11]; however 2014
American College of Cardiology/American Heart Associ-
ation guidelines propose a new classification scheme of
valvular disease severity, based on a combination of echo-
cardiographic and symptomatic parameters, with stages of
“at risk” to “progressive” to “asymptomatic severe” to
“symptomatic severe” [2]. Recent consensus statements
also endorse lower cut-off values for EROA for CIMR se-
verity as compared to primary MR. In part this is due to
1) data that shows worse prognosis at smaller EROA inCIMR, likely reflecting the effects of the incremental volume
load of lesser degrees of MR on an already dysfunctional
ventricle, and 2) 2D echocardiographic underestimation of
the flow convergence-method derived EROA due to “cres-
centic” orifice geometry in CIMR as opposed to a circular
orifice [2].
In addition to semi-quantitative and quantitative Dop-
pler techniques, it is important to integrate supportive and
complementary data into the overall severity grading.
Pulmonary venous flow reversal is specific for severe MR
although of lower sensitivity (Figure 7). Chamber enlarge-
ment (LA and LV), dense continuous wave MR Doppler
profile, and elevated E wave peak velocity >1.2 m/s are all
suggestive of severe MR [11-13] (Figures 8 and 9).
3D echocardiography has been demonstrated to pro-
vide accurate and reproducible MR grading using 3D
guided planimetry of the VC area, which is essentially
equivalent to the direct measure of the EROA. An
Table 4 Guideline based reference ranges for grading mr 2014 AHA/ACC Guidelines
2014 AHA/ACC Guidelines






CAD or cardiomyopathy, with normal
valve leaflets, chords, annulus
Regional WMA with
mild tethering of MV
Regional WMA ± LV
dilatation with severe
tethering of MV




mild loss of central
coaptation
Annular dilatation with
severe loss of central
coaptation
Annular dilatation with





No or mild dilatation with infarct or
inducible ischemia, or cardiomyopathy










Symptoms May be present, may respond to GDMT May be present, may
respond to GDMT




EROA-CIMR (cm2) < 0.2 < 0.2 ≥ 0.2 ≥ 0.2
Jet/LA area No MR jet or jet area/LA area <20% 20-39% ≥ 40% ≥ 40%
VC width (cm) < 0.3 ≥ 0.7 ≥ 0.7
Regurgitant Fraction < 50% ≥ 50% ≥ 50%
Regurgitant Volume < 30 mL ≥ 30 mL ≥ 30 mL
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does not require geometric assumptions that are used for
2D EROA calculation. Disadvantages are the lower frame
rates of 3D color Doppler, which can effect lateral reso-
lution and hence may erroneously exaggerate the area
measured [14].
Finally, CIMR is a dynamic process, and the echocar-
diographer must consider how ambient preloading and
afterloading conditions such as patient’s volume status,
systemic blood pressure, and medications may affect the
observed degree of MR.Figure 7 Reversal of pulmonary vein flow. Pulsed wave Doppler interro
view shows systolic reversal of flow. This is a specific, albeit lower sensitivitEchocardiographic assessment of global LV enlargement
and dysfunction
Quantitative measures have attempted to correlate LV
systolic dysfunction and LV dilatation with CIMR. Ele-
gant experimental observations show that isolated LV
systolic dysfunction (pharmacologically induced in a
large animal model) does not produce significant MR
[6,15]. This is likely because without tethering forces, rela-
tively little closing force is required to be generated by the
LV to force the mitral leaflets toward the annular coapta-
tion zone. However, in the same model of pharmacologicgation of the right upper pulmonary vein in this apical four chamber
y, sign of severe MR.
Figure 8 Pulsed wave Doppler of transmitral flow. Pulsed wave Doppler interrogation from the apical four chamber view of the transmitral
diastolic flows into the LV can provide adjunct information to grading of MR severity. In this example, the E wave measures approximately 1.6 m/s, and
this is consistent with a high flow rate of early diastolic passive LV filling which can be seen with severe MR.
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by relieving an extrinsic pericardial restraint, MR was gen-
erated. This observation confirms as a key mechanism the
apical and outward dilatation of PMs which create tether-
ing forces on the leaflets.
In CIMR with symmetric tethering, LV end-systolic and
end-diastolic volumes and the sphericity index correlate
with the severity of MR. This is because the degree of LV
dilatation directly relates to apical displacement of the
PMs. For asymmetric tethering phenotypes the measuresFigure 9 Dense Doppler Signature in Severe MR. This
continuous wave Doppler interrogation of an MR jet taken from the
apical four chamber view shows a very dense Doppler profile, which
is consistent with severe MR. The peak MR velocity is 4.5 m/s, and
this value would be used in the denominator of the calculation
of EROA.of global LV remodeling do not as robustly correlate with
severity of MR because a small infarct can disrupt PM
geometry and generate severe MR; the actual measures of
mitral valve deformation are better predictors (see below).
LV dilatation would therefore not be an independent pre-
dictor of CIMR severity in a population with mixed CIMR
phenotypes.
Local LV remodelling and PM displacement
The normal orientation of the PMs is with their long axis
parallel to that of the LV and perpendicular to the plane of
the mitral annulus. A local infarct that disrupts myocar-
dium underlying a PM can radically change the relation-
ship of that PM relative to the other PM and to the valve
apparatus. This asymmetric effect of the infarct on the
posteromedial PM translates directly into creating asym-
metry in mitral valve apparatus anatomy and function –
by rotating the posteromedial PM, tethering the posterior
leaflet, and deforming the posterior portion of the mitral
annulus – which creates a substrate for eccentric CIMR
(Figure 3 and Additional file 1). Several lines of ex-
perimental and echocardiographic evidence correlate
post-infarct inferoposterior wall motion abnormality with
severity of MR [16]. Direct evidence that PM displacement
generates CIMR was obtained in a sheep study of
echocardiography-guided PM repositioning by an inflat-
able balloon external to the myocardium [17]. In this
study, a Dacron patch with an adjustable balloon was sewn
epicardially over areas of infarct after circumflex artery
ligation; inflation of the balloon could be tailored to re-
duce the ischemic dilatation of the inferior wall, thus re-
approximating PM geometry, and reducing severity of MR
without a change in measures of LV contractility.
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displacement requires intracardiac landmarks. The anter-
ior mitral annulus is anchored at the aortomitral fibrous
curtain, and this point in the parasternal long axis or ap-
ical four chamber views can provide a reference for mea-
surement of apical displacement of both PM heads
(Figure 10B,C) [18]. In a population of 128 LV systolic dys-
function patients, the strongest multivariate correlationsA
C D
Figure 10 Representative measurements of tenting height, tenting an
height, tenting area, and tenting angles in a mid-systolic parasternal long a
the annulus line to the coaptation point (red hatched line) represents tenti
from the annular line to the coaptation zone to delineate an area (yellow s
sured as the angle that the mitral leaflets create with the mitral annulus lin
PM in the apical four chamber view (green line), and Panel C shows measu
three chamber view (pink line). Panel D shows a representative parasternal
cross-section. A reference grid of a mid-septal perpendicular chord (white l
another line orthogonal to and originating from the center of the first line
allows posterior displacements of both PMs to be measured (blue lines), as
Intra-PM distance is shown by the red line. These distances are all elevated
overlap in the distances among symmetric and asymmetric CIMR phenotyp
asymmetric CIMR as compared to the anterolateral PM (see Table 5).with MR severity in a functional MR model were the ap-
ical displacement of the posteromedial PM and the infero-
posterior displacement of the anterolateral PM [18]. In the
parasternal short axis view at the mid-ventricular level,
PM body displacements may be referenced relative to the
mathematical center of the LV. Agricola and colleagues
constructed a “mid-septal perpendicular line,” bounded by
the septal insertions of the right ventricle myocardium,B
gles, and tenting area. Panel A shows the measurement of tenting
xis TTE image. The mitral annulus line is drawn and the distance from
ng height. The posterior and anterior leaflets’ silhouettes are traced
hading) that represents the tenting area. Tethering angles are mea-
e. Panel B shows measurement of apical displacement the anterolateral
rement of apical displacement the posteromedial PM in the apical
short-axis mid-ventricular level view in early systole with PM bodies in
ine) spanning the septal insertions of right ventricle myocardium and
(hatched white line) was created. The mid-septal perpendicular chord
well as to measure lateral displacements of both PMs (yellow lines).
in CIMR compared to normal controls. Though there is significant
es, relative displacements of the posteromedial PM are increased in
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PMs (Figure 10D) [7]. Lateral displacements of both PMs
were measured from a second line constructed orthogonal
to the mid-septal perpendicular line. Finally, a distance be-
tween the papillary body muscles was recorded. Regardless
of CIMR phenotype, absolute value of each of these dis-
placement measures is higher when compared to normal
controls. In addition, the displacement measures will tend
to be higher in symmetric versus asymmetric CIMR, but
the magnitude of the changes between phenotypes is a few
millimeters and thus not sufficient to differentiate them
without other information on mitral valve deformation
(Table 5). Some differences correlate with asymmetric
phenotypes, e.g. the ratio of posterior displacements of the
posteromedial:anterolateral PMs is about 1.2 in asymme-
tric CIMR but about 0.94 in symmetric CIMR or normal
controls [7]. 3D TTE permits additional insight into the
geometric angles relating both PMs to the LV cavity long
axis, with greater asymmetry in the angles in CIMR versus








Tenting area 0.6 cm2-0.8 cm2
Tenting volume 2.3 mL
PM Anatomy
Posterior displacement: ALPM 1.7 cm
Posterior displacement: PMPM 1.6 cm
Lateral displacement: ALPM 1.2 cm
Lateral displacement: PMPM 1.2 cm
Apical displacement: ALPM 2.4 cm
Apical displacement: PMPM 2.4 cm-2.5 cm




Systolic area change 56%
Left Ventricle
Ejection fraction 55-70%
EDV (index) (35-75 mL/m2)
ESV (index) (12-30 mL/m2)
Sphericity Index 0.43
Wall motion score index 1.0
Data from: Zeng et al. [12,22]; Gelsomino et al. [23]; Veronesi et al. [19]; Agricola etTTE can be used to measure true spatial vector distances
from the aortomitral curtain to the PM tips [20] and also
characterize the spatial geometry of the PMs in relation to
the annulus [21].
Wall motion abnormalities are critically important in
gauging local LV dysfunction in CIMR: the echocardiog-
rapher should identify and quantify wall motion as part
of a comprehensive assessment of a global assessment of
ischemic burden. Indices of wall motion abnormalities
underlying the posteromedial PM insertion are highly
important in assessing CIMR. Novel methodologies,
including LV basal rotation dynamics as assessed by
speckle tracking, further highlight local differences be-
tween myocardial function in symmetric and asymmetric
phenotypes [10]. Normal systolic rotation may contrib-
ute to decreasing the distance from posterior PM head
to leaflet and mitral annular contraction. In a multivari-
able model, impairment of basal rotation was a key pre-
dictor of CIMR severity after inferoposterior MI, likely
because of less ability of myocardial rotation to reducebetween symmetric versus asymmetric CIMR in humans
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duction of mitral annular contraction.
PM dysfunction
Ischemic and/or systolic PM dysfunction itself does not
seem to contribute to CIMR on top of the contribution
of PM displacement. Kaul first reported poor overall cor-
relation of reduced PM thickening and MR severity in
canines [24]. In a sheep model of CIMR by left circum-
flex occlusion but with preserved PM blood supply via a
perfusion catheter from the aorta, withdrawal of the perfu-
sion catheter caused onset of papillary ischemia as mea-
sured by decreased strain rate but was correlated with
diminished tethering distances and reduced MR [25]. In
humans, there is some evidence that PM dysfunction, as
measured by longitudinal systolic strain, actually reduces
MR observed after inferior myocardial infarction [26]. Im-
pairment of PM contraction presumably reduces tension
on the chordae and paradoxically compensates for the
tethering forces exerted by PM misalignment and/or LV
dilatation. Novel protocols employing delayed enhance-
ment cardiac magnetic resonance imaging confirmed that
while PM infarct was observed in 30% of patients at
4 weeks after first myocardial infarction, neither partial
nor complete PM infarct robustly correlated with CIMR
[27]. These observations reinforce the notion that geomet-
ric PM displacement, and not necessarily systolic function,
is the key factor in determining CIMR.
Tethering and tenting of the mitral leaflets is the final
common pathway mediating leaflet malcoaptation and
incomplete closure in CIMR
The aggregate of the abnormal vector forces on the mitral
leaflets manifest echocardiographically as incomplete mi-
tral leaflet closure or tenting; as such it represents the
common pathway of LV remodelling and PM displace-
ment in CIMR. Various measures of quantifying tethering
and tenting are available by routine 2D TTE techniques.
The incomplete mitral leaflet closure pattern is often best
appreciated in the apical four chamber view, because the
mitral annular plane is defined in this view.
A single linear measure of “tenting height” – the max-
imal mid-systolic distance from mitral leaflet tips to the
annular plane – reflects the abnormal apical shift of the
coaptation zone (Figure 10A). While this measure has
been correlated with CIMR severity, tenting height under-
standably may be different when the tethering forces are
directed posterolaterally versus apically for example be-
cause height alone it does not account for angle of tether-
ing relative to the annular plane.
The tethering angles define the relationship of the base
of the leaflets to the annulus: α represents the angle be-
tween annular plane and anterior mitral leaflet and β the
angle between annular plane and posterior mitral leaflet[23]. 3D TTE and TEE acquisition of volumetric data sets
allows selection of particular imaging slices to calculate
tethering angles [22]. Though the exact values depend on
methodology and imaging plane selected, higher ratios of
posterior angle to anterior angle characterize the asym-
metric tenting phenotypes, and also predicts increased
MR severity [22].
Tenting area provides a more integrative measurement
that is less dependent on a particular angle, and also ac-
counts for the geometry of the entire leaflet and not just
that at the annular attachment. Tenting area is calculated
as the area bounded by the anterior and posterior leaflets
and the mitral annular plane (Figure 10); this measure-
ment is performed at mid-systole, when the tenting area
would be at a maximum. In the VALIANT-Echo substudy
of 341 patients with echocardiographic LV ejection
fraction <35% after myocardial infarct, tenting area was
the only independent predictor of progressively worsening
CIMR based on followup TTE data to a median
24.7 months [28]. Tenting area above a threshold of 4 cm2
predicted near 6 fold odds of having moderate or greater
MR at the end of followup and an odds ratio of 3.6 for in-
crease in the degree of MR. In patients with LV systolic
dysfunction, tenting area was a major determinant of func-
tional MR severity, independent of global LV function, LV
volume, and spherical shape. Tenting area itself correlates
with linear measures of apical or posterior PM displace-
ments [18]. Extending the analogy of assessment of tenting
beyond tenting height and tenting area, tenting volume as
defined by 3D echocardiography affords another level of
comprehensive measurement of mitral valve deformation.
However, the importance of the tenting phenotype must
be considered, because even with the same indices of
tenting height, area, or volume, an asymmetric CIMR
phenotype will likely be associated with more significant
MR (Figure 11).
Finally, secondary chordal attachments (basal or strut
chordae) to the anterior mitral valve leaflet may exert
additional geometric constraints on systolic MV config-
uration, most commonly manifesting as a bend, or an
angle, between the distal and basal portions of the anter-
ior mitral leaflet that further impairs coaptation. This
angle can give a qualitative visual clue, assessed as a
convexity or concavity in the configuration of the an-
terior mitral valve leaflet toward the left atrium in the
parasternal long axis view in systole, with concavity indi-
cating a bowing into the LV that strongly correlated with
CIMR severity [29].
Mitral annular dilatation
The mitral annulus has a specialized 3D geometry lik-
ened to an ovoid saddle shape that reduces stresses on
the leaflets and supports valvular competence [30]. Dila-
tation of the annulus may occur secondary to either LV
Figure 11 Symmetric tenting due to ischemic LV dilatation. These TTE images were obtained from a 72 year-old male with severe
multivessel coronary disease and an advanced ischemic cardiomyopathy with LV ejection fraction of 14% and an LV end-diastolic dimension of
71 mm prior to coronary bypass surgery. A phenotype of symmetric tethering is depicted by these mid-systole images obtained from the apical
three chamber view (A) and apical four chamber view (B). The parasternal long axis view is shown as panel A of Figure 4. Measured in the
parasternal long axis image, the tenting height was 1.4 cm, the tenting area was 4.0 cm2 and the tethering angles β and α were equal.
MR severity was graded as trace. Compared to the patient described in Figure 3, the same tenting height and tenting area were associated with
markedly distinct CIMR severity, reiterating that tenting phenotype is of utmost importance in determining severity.
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along the posterior annulus, even the fibrous anterior por-
tion of the mitral annulus may dilate [31,32]. Additionally,
dilatation along the posterior annulus may be asymmetric,
with a predilection for the region of the posterior commis-
sure (P2 – P3 segment).
Annular dilatation can cause an incomplete coaptation
pattern due to insufficient available leaflet area. How-
ever, the degree of dilatation does not necessarily correl-
ate with the severity of CIMR. Distortion of the native
3D annular geometry to a “flattened” annulus may also
contribute to CIMR by changing the leaflet motion.
However in a study of lone atrial fibrillation patients
with annular dilatation but normal LV chamber size, sig-
nificant MR was not observed [33]. This is because LV
remodelling and dilatation is required to generate tether-
ing forces, though the study did show a weak correlation
between functional MR severity and annular area.
Annular dilatation can be measured by anterior and
posterior dimensions, annulus area (apical four chamber
mitral annulus dimension multiplied by apical two cham-
ber mitral annulus dimension multiplied by π/4) and per-
haps with more computationally sophisticated methods
such as the MVQ software package (Mitral Valve Quanti-
fication, Phillips). Surveillance of mitral annular dilatation
is a part of our practice because of a self-propagating cycle
of annular dilatation→MR→ LV dilatation→ annular
dilatation. Mitral annular contraction, equal to (diastolic
annular area – systolic annular area)/diastolic annular
area, has a negative correlation with MR severity in LV
systolic dysfunction [18] and in post-infarct MR.Mitral leaflet area
Work by Robert Levine at Massachusetts General Hos-
pital has described 3D echocardiographic methods to
compare the areas of the mitral leaflets to the “closing
area” and the annular area [34,35]. In human models of
functional MR, the mitral leaflet areas are greater than
in patients without dilatation or prior infarct. However,
the ratio of the measured mitral leaflet area to the calcu-
lated “closing area” is decreased in functional MR. There
may a threshold lower ratio which would be consistent
with diagnosing a functional MR mechanism; it may be
possible in the future to echocardiographically detect,
measure and monitor this process as a means of asses-
sing the remodelling response to CIMR. The biologic re-
sponse that allows the valve to remodel by enlargement
and thickening seems to be due to reactivation of em-
bryonic development pathways occurring within the leaf-
let tissue [36].
Assessment of CIMR post-therapy
Echocardiography post-annuloplasty
The mechanisms responsible for recurrence of CIMR
after surgical revascularization and restrictive annulo-
plasty remain elusive. In some instances, the mechanism
is ongoing adverse LV dilatation and spherical remodel-
ling that worsens tethering [37,38]. In a single center
retrospective population of predominantly ischemic MR,
preoperative LV end diastolic diameter indexed to body
surface area with a cut-off of >3.5 cm/m2 predicted re-
currence of MR [39]. A greater degree of anterior mitral
leaflet tethering angle α, specifically >36.9° (considered
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tethering), regardless of LV dilatation or geometry, con-
ferred a multivariate OR of 3.6 for recurrent MR at
44.7 month follow-up of CIMR patients who underwent
surgical revascularization and undersized ring annulo-
plasty [40]. This is in accord previous results showing α
≥39.5° conferred OR of 3.1 for recurrent MR in a similar
population of patients who underwent surgical revascu-
larization and undersized ring annuloplasty [41]. There
was also a strong association (OR >4) for lack of LV re-
verse remodeling post-operatively. The results of this
line of analysis underscores that preoperative echocardi-
ography and tethering geometry does predict postopera-
tive outcomes including MR recurrence, LV geometry,
and outcome, and thus these should be part of preopera-
tive assessment. Preoperative diastology may also impact
postoperative outcome, with transmitral deceleration
time <140 ms predictive of MR recurrence, and deceler-
ation time and pulmonary vein systolic:diastolic flow ra-
tio predictive of mortality [42].
Because annuloplasty shifts the coaptation zone more
anteriorly, the posteromedial PM location can be further
distorted and lie outside the annulus ring; the tethering
effect on the posterior leaflet makes it less likely to coapt
at the anteriorly shifted coaptation zone [43]. In patients
without continued global LV dilatation, recurrent MR is
highlighted by adverse anterior leaflet tethering due to




Derangements in peak systolic longitudinal, radial, and
circumferential strain measures mirror underlying wall
motion abnormalities in both asymmetric or symmetric
CIMR [13]. In symmetric CIMR, peak systolic strain was
reduced globally, while in asymmetric CIMR phenotypes
there was more localized systolic strain derangements in
the inferoseptal and inferior territories. While it is not
yet clear how strain might add to the diagnosis of CIMR,
it could assume a particular role in surgical planning: in
a 61 patient CIMR cohort, strain did not improve after
surgical revascularization and restrictive annuloplasty in
the symmetric group, but did improve at one year in the
asymmetric group [13].
Exercise echocardiography
Patients with mild (or “progressive”) rest CIMR may ex-
hibit more severe inducible regurgitation as assessed by
flow convergence methods [13], and this may represent
the etiologies of exertional symptoms [44] and excess
mortality seen with CIMR [45]. Exercise physiology
exerts multiple effects that bear on the mitral valve ap-
paratus and degree of MR: inotropy increases whichaugments global and regional LV systolic dysfunction and
has the potential to improve mitral valve coaptation geom-
etry; against this, exercise contributes to increased LV sys-
tolic pressure and increased chronotropy with shortened
systolic time, which contribute to augmented transmitral
LV to left atrial pressure gradient [46]. Additionally,
exercise-induced ischemia could contribute to new or
worsened WMA and tethering, or increased heart rate
and altered loading conditions may result in worsening
of ventricular mechanics which in setting of underlying
akinesis or dyskinesis, result in increased MR. The net
change in ischemic MR with exercise depends ultim-
ately on which factor(s) represent the underlying mech-
anism of the ischemic MR: about one-quarter of CIMR
patients show decrease ischemic MR with exercise [47],
e.g. those with inferior myocardial infarction who can
augment LV function with exercise and who would not
have worsened ventricular mechanics.
Exercise may present a method to risk stratify patients
with LV systolic dysfunction and mild rest CIMR at rest,
as cardiovascular mortality at 19 month followup was
predicted by worsening of mild rest CIMR (judged by an
increase in EROA ≥13 mm2 on a symptom-limited semi-
supine bicycle exercise test for which beta blockers were
held for 24 hours) [47]. In another study of submaximal
Bruce protocol treadmill exercise with patients on beta
blockers, no rest echocardiographic parameters pre-
dicted severity of exercise-induced CIMR by EROA; in-
stead only changes in exercise-induced mitral geometry
measured by valve tenting area and coaptation distance
represented the independent predictors of ischemic MR
severity [48]. Exercise echocardiography may be reason-
able in patients with ischemic heart disease and sus-
pected CIMR who report dyspnea disproportionate to
rest MR and/or LV dysfunction or who experience pul-
monary edema without explained cause, and for whom
additional information would answer whether surgery
would benefit [13,46].
Transesophageal Echocardiography (TEE)
TEE can be a useful adjunct to TTE for characterizing
the mechanism of MR (particularly for intrinsic leaflet
pathologies) and mapping anatomic defects. It may help
exclude an organic etiology when assessing the patient
with CIMR, and also provide better spatial resolution of
chordal and leaflet geometric relationships. The use of
TEE intraoperatively and post-operatively in the evalu-
ation of MR has been comprehensively reviewed by
Sidebotham et al. [49] and Shakil et al. [50]. TEE is im-
portant in assessment of patients undergoing surgical re-
vascularization as it provides another opportunity to
assess for CIMR. However, because of vasodilating ef-
fects of anesthesia, CIMR severity may be underesti-
mated by intraoperative TEE. One proposed tactic to
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pressors to mimic more physiologic afterload conditions.
In a single study, the proxy for physiologic afterload was a
systolic blood pressure of 160 mmHg though the exact
target is debatable; concurrent with vasopressor adminis-
tration, most patients’ pulmonary artery occlusion pres-
sure rose and only a few patients were administered extra
intravenous fluid to combat the venodilating effects of
anesthesia [51].
Cardiac computed tomography and magnetic resonance
Non-echocardiographic cardiac imaging modalities are
being deployed to study CIMR. These techniques may
require the patient to remain immobile and flat and to
perform breath holds – potential issues for patients with
orthopnea due to cardiomyopathy or MR. Computed
tomography implies a radiation exposure and magnetic
resonance may require significant time as well as spe-
cialized equipment. Nevertheless, robust data sets with
axial and three dimensional information may be derived
which are suitable for a comprehensive classification of
the interwoven geometry of the components of the mi-
tral valve apparatus, for example augmented definition
of annulus dimensions, annulus height, shape, and tent-
ing height and angles [31,52,53] Delayed enhancement
cardiac magnetic resonance and CT also offer alternative
routes to more precise definition of region of PM and
LV myocardial infarct [27], and are thus useful to estab-
lish the underlying ischemic etiology of MR and also de-
fine myocardial viability which may impact treatment
decision-making [2]. The role of computed tomography
and magnetic resonance remains to be defined.
Conclusion
CIMR is the post-infarct pathophysiologic result of in-
complete mitral valve coaptation due to global or local
geometric deformity of the LV that generates apical dis-
placement of normal mitral valve leaflets. Echocardio-
graphic techniques can quantitate CIMR primarily by
indices of leaflet tethering and tenting, effectively inte-
grating the effects of multiple disparate forces. Because
CIMR may beget CIMR through mechanisms of in-
creased volume loading on the LV and annular dilata-
tion, precise echocardiographic diagnosis and followup
are essential. Improved echocardiographic assessments
will augment our understanding of the etiologies CIMR,
and translate to appropriate, mechanistically-targeted
therapy. The typical therapy of CIMR has been restrict-
ive mitral annuloplasty, but reshaping the annulus can-
not alone solve the problem when the ultimate etiologic
lesion is in ventricular geometry. This dilemma is appre-
ciated in practice as it is not proven that current treat-
ments of CIMR either boosts survival, helps LV reverse
remodeling, or improves symptoms. Better definitionsand improved phenotyping of CIMR will permit robust
randomized controlled trials of surgical therapies [54], as
well as refinements in percutaneous device therapies
such as CRT (which reduces tethering and modifies tim-
ing of LV systolic forces) [55] and injectable polymers to
reshape the posteromedial PM [56], novel surgical ap-
proaches (e.g. targeted surgical approaches such as
LVplasty, annuloplasty and chordal cutting depending
on the patient’s specific CIMR mechanism), and experi-
mental devices to improve PM geometry [57].
Additional file
Additional file 1: TTE image of asymmetric CIMR developing after
inferoposterior myocardial infarction. This video shows a TTE
parasternal long axis loop taken from the same patient as described in
Figure 3, and it demonstrates the inferobasal aneurysm and asymmetric
tenting due to more severe tethering of the posterior mitral leaflet than
the anterior mitral leaflet (the underlying rhythm is atrial fibrillation and the
effects of variable heart rate must be appreciated by the echocardiographer as
it may confound analysis).
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